- Report
- February 2024
- 120 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- December 2023
- 117 Pages
Global
From €4269EUR$4,450USD£3,667GBP
- Report
- March 2022
- 158 Pages
Global
From €5276EUR$5,500USD£4,532GBP
- Report
- July 2023
- 73 Pages
China
From €3358EUR$3,500USD£2,884GBP
- Report
- October 2021
- 118 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- December 2022
- 87 Pages
Asia Pacific
From €4221EUR$4,400USD£3,626GBP
- Report
- February 2022
- 120 Pages
Spain
From €2398EUR$2,500USD£2,060GBP
- Report
- January 2023
- 170 Pages
Global
From €2398EUR$2,500USD£2,060GBP
From €4557EUR$4,750USD£3,914GBP
- Report
- February 2024
- 71 Pages
Italy
From €4557EUR$4,750USD£3,914GBP
- Report
- February 2024
- 71 Pages
United Kingdom
From €4557EUR$4,750USD£3,914GBP
- Report
- April 2023
- 70 Pages
Canada
From €4557EUR$4,750USD£3,914GBP
- Report
- April 2023
- 75 Pages
Japan
From €4557EUR$4,750USD£3,914GBP
- Report
- April 2023
- 70 Pages
Mexico
From €4557EUR$4,750USD£3,914GBP
- Report
- April 2023
- 71 Pages
South Africa
From €4557EUR$4,750USD£3,914GBP
- Report
- January 2022
- 90 Pages
Spain
From €4557EUR$4,750USD£3,914GBP
- Report
- January 2022
- 90 Pages
Netherlands
From €4557EUR$4,750USD£3,914GBP
- Report
- January 2022
- 90 Pages
Argentina
From €4557EUR$4,750USD£3,914GBP
- Report
- August 2020
- 90 Pages
Brazil
From €3118EUR$3,250USD£2,678GBP
- Report
- August 2020
- 90 Pages
United States
From €3118EUR$3,250USD£2,678GBP
The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more